Tuesday, January 30, 2018

Pfizer Plans $5 Billion Boost in U.S. Manufacturing From Tax-Law Changes

Pfizer Inc. offered a rosy outlook for the year, outlining the benefits from the new U.S. tax law and casting the Amazon.com Inc.-led partnership to lower health-care costs as positive for the drug industry.

from WSJ.com: US Business http://ift.tt/2rRGOvI
via IFTTT

No comments:

Post a Comment